Table of Contents
Table of Contents
Preface pp. i-x
First Section pp. 1-2
Chapter 1. Hepatic Failure as an Early Complication Following Orthotopic Liver Transplantation
(Linda E. Muñoz, Paula Cordero, Idalia A. Cura, Guillermo Delgado, Homero Zapata, Edelmiro Pérez, Homero Nañez and Miguel M. Escobedo, Autonomous University of Nuevo León (UANL), Monterrey, Mexico)pp. 3-14
Chapter 2. Neurological Complications in Liver Transplantation
(Mónica B. Jiménez-Castro, Maria Elias-Miró and Carmen Peralta, Institut d´Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain)pp. 15-44
Chapter 3. Hepatic Encephalopathy, Cerebral Blood Flow and the Changes in Oxidative Metabolism
(Peter Nissen Bjerring and Fin Stolze Larsen, Department of Hepatology, Rigshospitalet, Copenhagen, Denmark)pp. 45-58
Chapter 4. New Insight into the Molecular Roles in the Pathogenesis of Hepatic Encephalopathy
(Mingli Liu and Shanchun Guo, Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA)pp. 59-72
Chapter 5. Disordered Central Neural Regulation of the Cardiovascular System in Liver Failure
(Hongqun Liu, Lamees Almutlaq and Samuel S. Lee, University of Calgary, Liver Unit, Calgary, Canada)pp. 73-88
Chapter 6. Hepatic Microcirculation in Chronic Liver Disease
(Giusi Marrone and Jordi Gracia-Sancho, Barcelona Hepatic Hemodynamic Laboratory, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain)pp. 89-106
Chapter 7. Astrocytes and Endothelial Cells Behavior Found in Brain Hippocampus in Prehepatic Portal Hypertensive Rats
(A. Lemberg, M.A. Fernández, V. Turco, J.M. Cárcamo, M.P. Torres, P.F. Galassi Gerez and E. Filinger, Physiopathology, Department of Biological Sciences, Faculty of Pharmacy and Biochemistry, University of Buenos Aires. Buenos Aires, Argentina and others)pp. 107-118
Second Section pp. 119-120
Chapter 8. Direct Antiviral Agents for Chronic Viral Hepatitis Treatment
(N. Chueca, M. Álvarez, V. Guillot, A. Peña and F. García, Microbiology Service. Hospital Universitario San Cecilio, Granada, Spain)pp. 121-138
Chapter 9. Emergent Therapies in Acute Liver Failure
(Sheila Cristina L. Sanches, Leandra Náira Z. Ramalho and Fernando S. Ramalho, Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil)pp. 139-158
Chapter 10. Overview of Artificial Liver Support Systems in the World and New Promising Methods
(Kazuaki Inoue and Makoto Yoshiba, Department of Gastroenterology, Showa University Fujigaoka Hospital, Yokohama, Japan, and others)pp. 159-176
Chapter 11. Cell Therapy in Human Liver-Based Diseases
(Julio Plaza-Diaz, Sergio Muñoz-Quezada and Luis Fontana, Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, Spain, and others)pp. 177-196
Chapter 12. Emerging Therapies for Parenteral Nutrition-Associated Liver Failure in Children: A Focus on Preventative Strategies
(Adam W. Bartlett and Chee Yee Ooi, Department of Gastroenterology, Sydney Children’s Hospital Randwick, New South Wales, Australia, and others)pp. 197-218
Chapter 13. The Endocannabinoid System in Hepatic Encephalopathy: Pathophysiology and Therapeutic Potential
(Ramon Bartolí, Gemma Ódena and Ramon Planas, Centro de Investigacion Biomedical en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Barcelona, España, and others)pp. 219-234
Chapter 14. The Role of MicroRNA in Liver Failure and Hepatic Carcinogenesis
(Georgios Tsoulfas and Polyxeni Agorastou, University of Thessaloniki, Greece)pp. 235-250
Index pp. 251-253